In the trial, it cut deaths by about one-third in patients who were on ventilators because of coronavirus infection.
Those who were receiving oxygen therapy but were not on ventilators also saw improvement: their risk of dying was reduced by 20%. The steroid had no effect on people with less severe cases of COVID-19 — those not receiving oxygen or ventilation.
https://www.nature.com/articles/d41586-020-01824-5